CD34(+) progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg(null) mice

Thumbnail
Fulltext:
238385.pdf
Size:
1.651Mb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2021
Author(s)
Meer, J.M.R. van der
Jonge, P.K.J.D. de
Waart, A.B. van der
Geerlings, A.C.
Moonen, J.P.
Brummelman, J.
Klein, J.H.M. de
Vermeulen, Malou C.
Maas, R.J.A.
Schaap, N.P.M.
Hoogstad-van Evert, J.S. van
Ottevanger, P.B.
Jansen, J.H.
Hobo, W.A.
Dolstra, H.
Source
Oncoimmunology, 10, 1, (2021), article 1981049
ISSN
DOI
Publication type
Article / Letter to editor
If a DOI or any other persistent identifier is unavailable, please use the following repository identifier to link to this item: https://hdl.handle.net/2066/238385   https://hdl.handle.net/2066/238385
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.